NR4A1 and breast cancer: Traditionally, a number of clinicopathological characteristics, such as patient age, tumor size, histological grade, hormone receptor status, HER-2 status, lymphovascular invasion and lymph node involvement, have been used to determine the prognosis of breast cancer patients [6].